BWAY vs. KMTS, INMD, MDXG, SIBN, IRMD, CBLL, BBNX, AVNS, EMBC, and BVS
Should you be buying Brainsway stock or one of its competitors? The main competitors of Brainsway include Kestra Medical Technologies (KMTS), InMode (INMD), MiMedx Group (MDXG), SiBone (SIBN), iRadimed (IRMD), CeriBell (CBLL), Beta Bionics (BBNX), AVANOS MEDICAL (AVNS), Embecta (EMBC), and Bioventus (BVS). These companies are all part of the "medical equipment" industry.
Brainsway vs. Its Competitors
Brainsway (NASDAQ:BWAY) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.
Brainsway has higher revenue and earnings than Kestra Medical Technologies.
Brainsway has a net margin of 9.01% compared to Kestra Medical Technologies' net margin of 0.00%. Brainsway's return on equity of 7.35% beat Kestra Medical Technologies' return on equity.
In the previous week, Kestra Medical Technologies had 2 more articles in the media than Brainsway. MarketBeat recorded 4 mentions for Kestra Medical Technologies and 2 mentions for Brainsway. Brainsway's average media sentiment score of 0.76 beat Kestra Medical Technologies' score of 0.67 indicating that Brainsway is being referred to more favorably in the media.
30.1% of Brainsway shares are owned by institutional investors. 19.0% of Brainsway shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Brainsway presently has a consensus target price of $14.25, suggesting a potential upside of 11.33%. Kestra Medical Technologies has a consensus target price of $27.50, suggesting a potential upside of 80.33%. Given Kestra Medical Technologies' higher probable upside, analysts plainly believe Kestra Medical Technologies is more favorable than Brainsway.
Summary
Brainsway beats Kestra Medical Technologies on 8 of the 11 factors compared between the two stocks.
Get Brainsway News Delivered to You Automatically
Sign up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BWAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Brainsway Competitors List
Related Companies and Tools
This page (NASDAQ:BWAY) was last updated on 7/3/2025 by MarketBeat.com Staff
